Immunohistochemical study of the inflammatory infiltrate associated with equine squamous cell carcinoma.
The distribution of T (CD3), B (CD79) lymphocytes, immunoglobulin (IgG, IgM and IgA)-producing plasma cells, macrophages (lysozyme, Mac387) and MHC Class II antigen was analysed in the inflammatory infiltrate associated with 19 equine squamous cell carcinomas (SCCs) and six cases of precancerous lesions (actinic keratosis). The SCCs came from the penis (11 cases), conjunctiva (four), skin (two), nasal cavity (one) and oral cavity (one). Seven cases were well-differentiated and 12 moderately differentiated. Nine cases showed no invasion of peritumoral deep tissues (locally invasive), whereas the remaining 10 cases were highly invasive. An abundant inflammatory infiltrate was associated with the majority of the SCCs and with lesions of actinic keratosis. This infiltrate was composed mainly of CD3(+)T lymphocytes, CD79(+)B cells and numerous IgG(+)plasma cells; IgM- and IgA-producing plasma cells were scarce and variable, respectively. Macrophages were usually numerous. Macrophages, lymphocytes, intra-epithelial dendritic cells and fibroblasts expressed MHC Class II antigen. No significant correlation was found between the nature of the inflammatory infiltrate and the SCC histological grade or degree of invasion, suggesting that the local anti-tumour immune response failed to prevent tumour invasion or metastasis. MHC Class II was expressed by a variable number of neoplastic epithelial cells in four SCCs, all of which were only locally invasive. In addition, in areas where SCC cells expressed Class II antigen, numerous CD3(+)T lymphocytes were present and some of them were associated with degenerate tumour cells. These findings suggest that the expression of MHC Class II by neoplastic cells induces an improved local anti-tumour immune response.
Pérez
J
J
Department of Comparative Pathology, Faculty of Veterinary Medicine, Córdoba, Spain.
Mozos
E
E
Martín
M P
MP
Day
M J
MJ
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000737:chemistry / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D002452:Cell Count / Q000662:veterinary; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006734:Horse Diseases / Q000276:immunology / Q000473:pathology*; D006736:Horses; D007124:Immunoenzyme Techniques / Q000662:veterinary; D007136:Immunoglobulins / Q000032:analysis; D007642:Keratosis / Q000276:immunology / Q000473:pathology / Q000662:veterinary; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D008297:Male; D010950:Plasma Cells / Q000276:immunology / Q000473:pathology; D011230:Precancerous Conditions / Q000737:chemistry / Q000276:immunology / Q000473:pathology / Q000662:veterinary; D012878:Skin Neoplasms / Q000737:chemistry / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000949:Histocompatibility Antigens Class II; D007136:Immunoglobulins